Role of the RNA recognition motif of the E1B 55kDa protein in the adenovirus type 5 infectious cycle

Virology

Volumn 417, Issue 1, 2011, Pages 9-17

  Kato, Sayuri E M ^a   Huang, Wenying ^a   Flint, S J ^a  

^a PRINCETON UNIVERSITY   (United States)

Author keywords

Adenovirus E1B 55kDa protein; RNA binding; RNA recognition motif

Indexed keywords

MESSENGER RNA; VIRUS PROTEIN; VIRUS RNA;

ADENOVIRUS 5; ARTICLE; CARBOXY TERMINAL SEQUENCE; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CROSS LINKING; PROTEIN DEGRADATION; PROTEIN MOTIF; RNA BINDING; VIRUS REPLICATION;

ADENOVIRUSES, HUMAN; AMINO ACID MOTIFS; FIBROBLASTS; GENE EXPRESSION REGULATION, VIRAL; GENOME, VIRAL; HELA CELLS; HUMANS; MUTATION; PROTEIN BINDING; RNA, VIRAL; ULTRAVIOLET RAYS; VIRAL PROTEINS; VIRUS REPLICATION;

ADENOVIRIDAE; HUMAN ADENOVIRUS TYPE 5;

EID: 79961004789     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2011.04.014     Document Type: Article

References (115)

1. Adam S., Dreyfuss G. Adenovirus proteins associated with mRNA and hnRNA in infected HeLa cells. J. Virol. 1989, 61:3276-3283.
2. Adam S., Nakagawa T., Swanson M.S., Woodruff T.K., Dreyfuss G. mRNA polyadenylate-binding protein: gene isolation and identification of a ribonucleoprotein consensus sequence. Mol. Cell. Biol. 1986, 6:2932-2943.
3. Aiello L., Guilfoyle R., Huebner K., Weinmann R. Adenovirus 5 DNA sequences present and RNA sequences transcribed in transformed human embryo kidney cells (HEK-Ad-5 or 293). Virology 1979, 94(2):460-469.
4. Ali H., LeRoy G., Bridge G., Flint S.J. The adenovirus L4 33-kilodalton protein binds to intragenic sequences of the major late promoter required for late phase-specific stimulation of transcription. J. Virol. 2007, 81(3):1327-1338.
5. Anderson C.W., Baum P.R., Gesteland R.F. Processing of adenovirus 2-induced proteins. J. Virol. 1973, 12(2):241-252.
6. Araujo F.D., Stracker T.H., Carson C.T., Lee D.V., Weitzman M.D. Adenovirus type 5 E4orf3 protein targets the Mre11 complex to cytoplasmic aggresomes. J. Virol. 2005, 79(17):11382-11391.
7. Aspegren A., Rabino C., Bridge E. Organization of splicing factors in adenovirus-infected cells reflects changes in gene expression during the early to late phase transition. Exp. Cell Res. 1998, 245(1):203-213.
8. Babich A., Feldman L.T., Nevins J.R., Darnell J.E., Weinberger C. Effect of adenovirus on metabolism of specific host mRNAs: transport control and specific translational discrimination. Mol. Cell. Biol. 1983, 3(7):1212-1221.
9. Babiss L.E., Young C.S.H., Fisher P.P., Ginsberg H.S. Expression of adenovirus E1A and E1B gene products and the Escherichia coli XPRT gene in KB cells. J. Virol. 1983, 46:454-465.
10. Bachi A., Braun I.C., Rodrigues J.P., Pante N., Ribbeck K., von Kobbe C., Kutay U., Wilm M., Gorlich D., Carmo-Fonseca M., Izaurralde E. The C-terminal domain of TAP interacts with the nuclear pore complex and promotes export of specific CTE-bearing RNA substrates. RNA 2000, 6(1):136-158.
11. Baker A., Rohleder K.J., Hanakahi L.A., Ketner G. Adenovirus E4 34k and E1b 55k oncoproteins target host DNA ligase IV for proteasomal degradation. J. Virol. 2007, 81(13):7034-7040.
12. Beltz G.A., Flint S.J. Inhibition of HeLa cell protein synthesis during adenovirus infection: restriction of cellular messenger RNA sequences to the nucleus. J. Mol. Biol. 1979, 131:353-373.
13. Berget S.M., Moore C., Sharp P.A. Spliced segments at the 5' terminus of adenovirus 2 late mRNA. Proc. Natl. Acad. Sci. U. S. A. 1977, 74:3171-3175.
14. Blackford A.N., Grand R.J. Adenovirus E1B 55-kilodalton protein: multiple roles in viral infection and cell transformation. J. Virol. 2009, 83(9):4000-4012.
15. Blanchette P., Cheng C.Y., Yan Q., Ketner G., Ornelles D.A., Dobner T., Conaway R.C., Conaway J.W., Branton P.E. Both BC-box motifs of adenovirus protein E4orf6 are required to efficiently assemble an E3 ligase complex that degrades p53. Mol. Cell. Biol. 2004, 24(21):9619-9629.
16. Blanchette P., Kindsmuller K., Groitl P., Dallaire F., Speiseder T., Branton P.E., Dobner T. Control of mRNA export by adenovirus E4orf6 and E1B55K proteins during productive infection requires E4orf6 ubiquitin ligase activity. J. Virol. 2008, 82(6):2642-2651.
17. Bridge E., Ketner G. Redundant control of adenovirus late gene expression by early region 4. J. Virol. 1989, 63:631-638.
18. Bridge E., Ketner G. Interaction of adenoviral E4 and E1b products in late gene expression. Virology 1990, 174:345-353.
19. Bridge E., Pettersson U. Nuclear organization of replication and gene expression in adenovirus-infected cells. The Molecular Repertoire of Adenoviruses I 1995, vol. 199/I:99-117. Springer-Verlag, Germany. W. Doerfler, P. Böhm (Eds.).
20. Cardoso F.M., Kato S.E., Huang W., Flint S.J., Gonzalez R.A. An early function of the adenoviral E1B 55kDa protein is required for the nuclear relocalization of the cellular p53 protein in adenovirus-infected normal human cells. Virology 2008, 378(2):339-346.
21. Carmody S.R., Wente S.R. mRNA nuclear export at a glance. J. Cell Sci. 2009, 122(Pt 12):1933-1937.
22. Carson C.T., Schwartz R.A., Stracker T.H., Lilley C.E., Lee D.V., Weitzman M.D. The Mre11 complex is required for ATM activation and the G2/M checkpoint. EMBO J. 2003, 22(24):6610-6620.
23. Carter C.C., Izadpanah R., Bridge E. Evaluating the role of CRM1-mediated export for adenovirus gene expression. Virology 2003, 315(1):224-233.
24. Cathomen T., Weitzman M.D. A functional complex of adenovirus proteins E1B-55kDa and E4orf6 is necessary to modulate the expression level of p53 but not its transcriptional activity. J. Virol. 2000, 74(23):11407-11412.
25. Cepko C.L., Sharp P.A. Assembly of adenovirus major capsid protein is mediated by a nonvirion protein. Cell 1982, 31:407-415.
26. Chodosh L.A. UV crosslinking of proteins to nucleic acids. Curr. Protoc. Mol. Biol. 2001, 5. Chapter 12, Unit 12.
27. Chow L.T., Gelinas R.E., Broker T.R., Roberts R.J. An amazing sequence arrangement at the 5' ends of adenovirus 2 messenger RNA. Cell 1977, 12:1-8.
28. Cuesta R., Xi Q., Schneider R.J. Adenovirus-specific translation by displacement of kinase Mnk1 from cap-initiation complex eIF4F. EMBO J. 2000, 19(13):3465-3474.
29. Cuesta R., Xi Q., Schneider R.J. Structural basis for competitive inhibition of eIF4G-Mnk1 interaction by the adenovirus 100-kilodalton protein. J. Virol. 2004, 78(14):7707-7716.
30. Cutt J.R., Shenk T., Hearing P. Analysis of adenovirus early region 4-encoded polypeptides synthesized in productively infected cells. J. Virol. 1987, 61:543-552.
31. Dallaire F., Blanchette P., Groitl P., Dobner T., Branton P.E. Identification of integrin alpha3 as a new substrate of the adenovirus E4orf6/E1B 55-kilodalton E3 ubiquitin ligase complex. J. Virol. 2009, 83(11):5329-5338.
32. Dobbelstein M., Roth J., Kimberly W.T., Levine A.J., Shenk T. Nuclear export of the E1B 55-kDa and E4 34-kDa adenoviral oncoproteins mediated by a rev-like signal sequence. EMBO J. 1997, 16:4276-4284.
33. Dolph P.J., Racaniello V., Villamarin A., Pallodino F., Schneider R.J. The adenovirus tripartite leader may eliminate the requirement of cap-binding protein complex during translation initiation. J. Virol. 1988, 62:2059-2066.
34. Dosch T., Horn F., Schneider G., Kratzer F., Dobner T., Hauber J., Stauber R.H. The adenovirus type 5 E1B-55k oncoprotein actively shuttles in virus- infected cells, whereas transport of E4Orf6 is mediated by a CRM1- independent mechanism. J. Virol. 2001, 75(12):5677-5683.
35. Endter C., Kzhyshkowska J., Stauber R., Dobner T. SUMO-1 modification required for transformation by adenovirus type 5 early region 1B 55-kDa oncoprotein. Proc. Natl. Acad. Sci. USA 2001, 98:11312-11317.
36. Endter C., Hartl B., Spruss T., Hauber J., Dobner T. Blockage of CRM1-dependent nuclear export of the adenovirus type 5 early region 1B 55-kDa protein augments oncogenic transformation of primary rat cells. Oncogene 2005, 24(1):55-64.
37. Erkmann J.A., Kutay U. Nuclear export of mRNA: from the site of transcription to the cytoplasm. Exp. Cell Res. 2004, 296(1):12-20.
38. Evans J.D., Hearing P. Relocalization of the Mre11-Rad50-Nbs1 complex by the adenovirus E4 ORF3 protein is required for viral replication. J. Virol. 2005, 79(10):6207-6215.
39. Farley D.C., Brown J.L., Leppard K.N. Activation of the early-late switch in adenovirus type 5 major late transcription unit expression by L4 gene products. J. Virol. 2004, 78(4):1782-1791.
40. Fischer A., Huber J., Boulens W.C., Mattaj I.W., Luhrmann R. The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell 1995, 82:475-483.
41. Flint S.J., Gonzalez R.A. Regulation of mRNA production by the adenoviral E1B 55kDa and E4 Orf6 proteins. Curr. Top. Microbiol. Immunol. 2003, 272:287-330.
42. Flint S.J., Beltz G.A., Linzer D. Synthesis and processing of SV40-specific RNA in adenovirus-infected, SV40-transformed human cells. J. Mol. Biol. 1983, 167:335-359.
43. Flint S.J., Huang W., Goodhouse J., Kyin S. A peptide inhibitor of exportin1 blocks shuttling of the adenoviral E1B 55kDa protein but not export of viral late mRNAs. Virology 2005, 337:7-17.
44. Fornerod M., Ohno M., Yoshida M., Mattaj I.W. CRM1 is an export receptor for leucine-rich nuclear export signals. Cell 1997, 90(6):1051-1060.
45. Gabler S., Schutt H., Groitl P., Wolf H., Shenk T., Dobner T. E1B 55-kilodalton-associated protein: a cellular protein with RNA- binding activity implicated in nucleocytoplasmic transport of adenovirus and cellular mRNAs. J. Virol. 1998, 72(10):7960-7971.
46. Gonzalez R.A., Flint S.J. Effects of mutations in the adenoviral E1B 55kDa protein coding sequence on viral late mRNA metabolism. J. Virol. 2002, 76:4507-4519.
47. Gonzalez R., Huang W., Finnen R., Bragg C., Flint S.J. Adenovirus E1B 55-kilodalton protein is required for both regulation of mRNA export and efficient entry into the late phase of infection in normal human fibroblasts. J. Virol. 2006, 80(2):964-974.
48. Goodrum F.D., Ornelles D.A. Roles for the E4 orf6, orf3, and E1B 55-kilodalton proteins in cell cycle-independent adenovirus replication. J. Virol. 1999, 73(9):7474-7488.
49. Gorlich D., Kutay U. Transport between the cell nucleus and the cytoplasm. Annu. Rev. Cell Dev. Biol. 1999, 15:607-660.
50. Graham F.L., Smiley J., Russell W.C., Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 1977, 36:59-72.
51. Granberg F., Svensson C., Pettersson U., Zhao H. Modulation of host cell gene expression during onset of the late phase of an adenovirus infection is focused on growth inhibition and cell architecture. Virology 2005, 343(2):236-245.
52. Hainaut P., Hollstein M. p53 and human cancer: the first ten thousand mutations. Adv. Cancer Res. 2000, 77:81-137.
53. Halbert D.N., Cutt J.R., Shenk T. Adenovirus early region 4 encodes functions required for efficient DNA replication, late gene expression, and host cell shutoff. J. Virol. 1985, 56:250-257.
54. Harada J.N., Berk A.J. p53-independent and -dependent requirements for E1B-55K in adenovirus type 5 replication. J. Virol. 1999, 73(7):5333-5344.
55. Harada J.N., Shevchenko A., Pallas D.C., Berk A.J. Analysis of the adenovirus E1B-55K-anchored proteome reveals its link to ubiquitination machinery. J. Virol. 2002, 76(18):9194-9206.
56. Hayes B.W., Telling G.C., Myat M.M., Williams J.F., Flint S.J. The adenovirus L4 100-kilodalton protein is necessary for efficient translation of viral late mRNA species. J. Virol. 1990, 64:2732-2742.
57. He T.C., Zhou S., da Costa L.T., Yu J., Kinzler K.W., Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. U. S. A. 1998, 95(5):2509-2514.
58. Hollstein M., Sidransky D., Vogelstein B., Harris C.C. p53 mutations in human cancers. Science 1991, 253(5015):49-53.
59. Horridge J.J., Leppard K.N. RNA-binding activity of the E1B 55-kilodalton protein from human adenovirus type 5. J. Virol. 1998, (11):9374-9379.
60. Huang J., Schneider R.J. Adenovirus inhibition of cellular protein synthesis involves inactivation of cap-binding protein. Cell 1991, 65:271-280.
61. Huang Y., Steitz J.A. SRprises along a messenger's journey. Mol. Cell 2005, 17(5):613-615.
62. Jayaram S., Bridge E. Genome concatenation contributes to the late gene expression defect of an adenovirus E4 mutant. Virology 2005, 342(2):286-296.
63. Kang Y., Bogerd H.P., Cullen B.R. Analysis of cellular factors that mediate nuclear export of RNAs bearing the Mason-Pfizer monkey virus constitutive transport element. J. Virol. 2000, 74(13):5863-5871.
64. Kao C.C., Yew P.R., Berk A.J. Domains required for in vitro association between the cellular p53 and the adenovirus 2 E1B 55K proteins. Virology 1990, 179(2):806-814.
65. Kenan D.J., Query C.C., Keene J.D. RNA recognition: towards identifying determinants of specificity. Trends Biochem. Sci. 1991, 16(6):214-220.
66. Kindsmuller K., Groitl P., Hartl B., Blanchette P., Hauber J., Dobner T. Intranuclear targeting and nuclear export of the adenovirus E1B-55K protein are regulated by SUMO1 conjugation. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(16):6684-6689.
67. Kohler A., Hurt E. Exporting RNA from the nucleus to the cytoplasm. Nat. Rev. Mol. Cell Biol. 2007, 8(10):761-773.
68. Kratzer F., Rosorius O., Heger P., Hirschmann N., Dobner T., Hauber J., Stauber R.H. The adenovirus type 5 E1B-55K oncoprotein is a highly active shuttle protein and shuttling is independent of E4orf6, p53 and Mdm2. Oncogene 2000, 19(7):850-857.
69. Kzhyshkowska J., Rusch A., Wolf H., Dobner T. Regulation of transcription by the heterogeneous nuclear ribonucleoprotein E1B-AP5 is mediated by complex formation with the novel bromodomain-containing protein BRD7. Biochem. J. 2003, 371(Pt 2):385-393.
70. Larkin M.A., Blackshields G., Brown N.P., Chenna R., McGettigan P.A., McWilliam H., Valentin F., Wallace I.M., Wilm A., Lopez R., Thompson J.D., Gibson T.J., Higgins D.G. Clustal W and Clustal X version 2.0. Bioinformatics 2007, 23(21):2947-2948.
71. Lassam N.J., Bayley S.T., Graham F.L. Tumor antigens of human Ad5 in transformed cells and in cells infected with transformation defective host range mutants. Cell 1979, 18:781-791.
72. Liu F., Green M.R. Promoter targeting by an adenovirus E1A through interaction with different cellular DNA-binding domains. Nature 1994, 368:520-525.
73. Liu Y., Shevchenko A., Berk A.J. Adenovirus exploits the cellular aggresome response to accelerate inactivation of the MRN complex. J. Virol. 2005, 79(22):14004-14016.
74. Lunt R., Vayda M.E., Young M., Flint S.J. Isolation and characterization of monoclonal antibodies against the adenovirus core proteins. Virology 1988, 164:275-279.
75. Luo K., Ehrlich E., Xiao Z., Zhang W., Ketner G., Yu X.F. Adenovirus E4orf6 assembles with Cullin5-ElonginB-ElonginC E3 ubiquitin ligase through an HIV/SIV Vif-like BC-box to regulate p53. FASEB J. 2007, 21(8):1742-1750.
76. Malim M.H., McCarn D.F., Tiley L.S., Cullen B.R. Mutational definition of the human immunodeficiency virus type 1 Rev activation domain. J. Virol. 1991, 65(8):4248-4254.
77. Maris C., Dominguez C., Allain F.H. The RNA recognition motif, a plastic RNA-binding platform to regulate post-transcriptional gene expression. FEBS J. 2005, 272(9):2118-2131.
78. Martin M.E., Berk A.J. Adenovirus E1B 55K represses p53 activation in vitro. J. Virol. 1998, 72(4):3146-3154.
79. Mathew S.S., Bridge E. The cellular Mre11 protein interferes with adenovirus E4 mutant DNA replication. Virology 2007, 365(2):346-355.
80. Miller D.L., Myers C.L., Rickards B., Coller H.A., Flint S.J. Adenovirus type 5 exerts genome-wide control over cellular programs governing proliferation, quiescence, and survival. Genome Biol. 2007, 8(4):R58.
81. Miller D.L., Rickards B., Mashiba M., Huang W., Flint S.J. The adenoviral E1B 55-kilodalton protein controls expression of immune response genes but not p53-dependent transcription. J. Virol. 2009, 83(8):3591-3603.
82. Ornelles D., Shenk T. Location of the adenovirus early region 1B 55 kilodalton protein during lytic infection: association with nuclear viral inclusions requires the early region 4 34-kilodalton protein. J. Virol. 1991, 65:424-439.
83. O'Shea C.C., Johnson L., Bagus B., Choi S., Nicholas C., Shen A., Boyle L., Pandey K., Soria C., Kunich J., Shen Y., Habets G., Ginzinger D., McCormick F. Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity. Cancer Cell 2004, 6(6):611-623.
84. Pilder S., Moore M., Logan J., Shenk T. The adenovirus E1B-55kd transforming polypeptide modulates transport or cytoplasmic stabilization of viral and host cell mRNAs. Mol. Cell. Biol. 1986, 6:470-476.
85. Pombo A., Ferreira J., Bridge E., Carmo-Fonseca M. Adenovirus replication and transcription sites are spatially separated in the nucleus of infected cells. EMBO J. 1994, 13(21):5075-5085.
86. Puvion-Dutilleul F., Bachellerie J.P., Visa N., Puvion E. Rearrangements of intranuclear structures involved in RNA processing in response to adenovirus infection. J. Cell Sci. 1994, 107(Pt 6):1457-1468.
87. Querido E., Morrison M.R., Chu-Pham-Dang H., Thirlwell S.W., Boivin D., Branton P.E. Identification of three functions of the adenovirus e4orf6 protein that mediate p53 degradation by the E4orf6-E1B55K complex. J. Virol. 2001, 75(2):699-709.
88. Rabino C., Aspegren A., Corbin-Lickfett K., Bridge E. Adenovirus late gene expression does not require a Rev-like nuclear RNA export pathway. J. Virol. 2000, 74(14):6684-6688.
89. Reed R., Cheng H. TREX, SR proteins and export of mRNA. Curr. Opin. Cell Biol. 2005, 17(3):269-273.
90. Reich N.C., Levine A.J. Growth regulation of a cellular tumor antigen, p53, in non-transformed cells. Nature 1984, 308:199-201.
91. Sarnow P., Sullivan C.A., Levine A.J. A monoclonal antibody detecting the Ad5 E1B-58K tumor antigen in adenovirus-infected and transformed cells. Virology 1982, 120:387-394.
92. Sarnow P., Hearing P., Anderson C.W., Halbert D.N., Shenk T., Levine A.J. Adenovirus early region 1B 58,000-dalton tumor antigen is physically associated with an early region 4 25,000-dalton protein in productively infected cells. J. Virol. 1984, 49:692-700.
93. Schwartz R.A., Lakdawala S.S., Eshleman H.D., Russell M.R., Carson C.T., Weitzman M.D. Distinct requirements of adenovirus E1b55K protein for degradation of cellular substrates. J. Virol. 2008, 82(18):9043-9055.
94. Spurgeon M.E., Ornelles D.A. The adenovirus E1B 55-kilodalton and E4 open reading frame 6 proteins limit phosphorylation of eIF2alpha during the late phase of infection. J. Virol. 2009, 83(19):9970-9982.
95. Stracker T.H., Carson C.T., Weitzman M.D. Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex. Nature 2002, 418(6895):348-352.
96. Stutz F., Rosbash M. Nuclear RNA export. Genes Dev. 1998, 12(21):3303-3319.
97. Swanson M.S., Nakagawa T.Y., LeVan K., Dreyfuss G. Primary structure of human nuclear ribonucleoprotein particle C proteins: conservation of sequence and domain structures in heterogeneous nuclear RNA, mRNA, and pre-rRNA-binding proteins. Mol. Cell. Biol. 1987, 7(5):1731-1739.
98. Teodoro J.G., Branton P.E. Regulation of p53-dependent apoptosis, transcriptional repression, and cell transformation by phosphorylation of the 55-kilodalton E1B protein of human adenovirus type 5. J. Virol. 1997, 71(5):3620-3627.
99. Thompson J.D., Higgins D.G., Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994, 22(22):4673-4680.
100. Tormanen H., Backstrom E., Carlsson A., Akusjarvi G. L4-33K, an adenovirus-encoded alternative RNA splicing factor. J. Biol. Chem. 2006, 281(48):36510-36517.
101. Tribouley C., Lutz P., Staub A., Kedinger C. The product of the adenovirus intermediate gene IVa2 is a transcription activator of the major late promoter. J. Virol. 1994, 68:4450-4457.
102. Weis K. Importins and exportins: how to get in and out of the nucleus. Trends Biochem. Sci. 1998, 23(5):185-189.
103. Williams J.F. Oncogenic transformation of hamster embryo cells in vitro by adenovirus type 5. Nature 1973, 243:162-163.
104. Williams J., Karger B.D., Ho Y.S., Castiglia C.L., Mann T., Flint S.J. The adenovirus E1B 495R protein plays a role in regulating the transport and stability of the viral late messages. Cancer Cells 1986, 4:275-284.
105. Woo J.L., Berk A.J. Adenovirus ubiquitin-protein ligase stimulates viral late mRNA nuclear export. J. Virol. 2007, 81(2):575-587.
106. Xi Q., Cuesta R., Schneider R.J. Tethering of eIF4G to adenoviral mRNAs by viral 100k protein drives ribosome shunting. Genes Dev. 2004, 18(16):1997-2009.
107. Yang U.-C., Huang W., Flint S.J. mRNA export correlates with activation of transcription in human subgroup C adenovirus-infected cells. J. Virol. 1996, 70:4071-4080.
108. Yatherajam G., Huang W., Flint S.J. Export of adenoviral late mRNA from the nucleus requires the Nxf1/Tap export receptor. J. Virol. 2011, 85(4):1429-1438.
109. Yew P.R., Berk A.J. Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein. Nature 1992, 357(6373):82-85.
110. Yew P.R., Kao C.C., Berk A.J. Dissection of functional domains in the adenovirus 2 early 1B 55k polypeptide by suppressor-linker-insertional mutagenesis. Virology 1990, 179:795-805.
111. Yew P.R., Liu X., Berk A.J. Adenovirus E1B oncoprotein tethers a transcriptional repression domain to p53. Genes Dev. 1994, 8(2):190-202.
112. Yueh A., Schneider R.J. Selective translation initiation by ribosome jumping in adenovirus-infected and heat-shocked cells. Genes Dev. 1996, 10(12):1557-1567.
113. Zhang Y., Schneider R.J. Adenovirus inhibition of cell translation facilitates release of virus particles and enhances degradation of the cytokeratin network. J. Virol. 1994, 68(4):2544-2555.
114. Zhang L., Zhang K., Prandl R., Schoffl F. Detecting DNA-binding of proteins in vivo by UV-crosslinking and immunoprecipitation. Biochem. Biophys. Res. Commun. 2004, 322(3):705-711.
115. Zhao H., Granberg F., Pettersson U. How adenovirus strives to control cellular gene expression. Virology 2007, 363(2):357-375.